🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04008329
Recruiting Observational

A Registered Cohort Study on Amyotrophic Lateral Sclerosis

NCT04008329 · tracked via the Priya Life Science China tracker
Sponsor
First Affiliated Hospital of Fujian Medical University
Phase
Observational
Started
2019-07-05
Last updated
2021-03-22

Condition(s) studied

Amyotrophic Lateral Sclerosis

Study summary

Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * Amyotrophic Lateral Sclerosis patients fulfilling the El Escorial criteria (including definite, probable and possible) * Progressive muscular atrophy * Primary lateral sclerosis * Progressive bulbar palsy Exclusion Criteria: * History of serious head trauma or neuropsychiatric disease * Decline to participate

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Neurology, First Affiliated Hospital of Fujian Medical University Fuzhou Fujian Recruiting

More First Affiliated Hospital of Fujian Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04008329 on ClinicalTrials.gov ↗ ← All trials in China